NVCR Q4 2018 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena

NVCRNovoCure Limited

$1B

Q4 2018 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$70M+29.8% YoY

Gross Profit

$47M66.9% margin

Operating Income

-$9M-12.4% margin

Net Income

-$16M-22.4% margin

EPS (Diluted)

$-0.17

QoQ Revenue Growth

+7.6%

Cash Flow

Operating Cash Flow

$17M

Free Cash Flow

$15M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$340M

Total Liabilities

$228M

Stockholders' Equity

$112M

Cash & Equivalents

$141M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$70M	$54M	+29.8%
Gross Profit	$47M	$38M	+22.7%
Operating Income	-$9M	-$5M	-92.3%
Net Income	-$16M	-$11M	-42.8%

Geographic Segments

UNITED STATES

$44M63%

E M E A

$23M32%

JAPAN

$3M4%